Black Friday deals are live on Amazon · limited-time discounts, grab them before they’re goneGrab the deals
Guide

Are Reishi Mushrooms Psychedelic? No, and Here's Why

Basket of wild mushrooms in a forest
Mushroom Identifiers Editorial Team

Field Guides & Mushroom Safety

Updated

Apr 26, 2026

— views

No, reishi mushrooms are not psychedelic. Reishi is not known to cause hallucinations or a high. Its main active compounds are beta-glucans and triterpenes, and we found no study reporting psilocybin in it. Magic mushrooms work through psilocybin, which acts on serotonin receptors in the brain. Reishi still carries real risks, including rare liver injury and added bleeding risk with blood thinners.

This page answers "are reishi mushrooms psychedelic" by comparing reishi with psilocybin mushrooms and Amanita muscaria. It then covers what the evidence says reishi supplements can and cannot do, plus side effects, liver case reports and drug interactions. It gives no guidance on using any psychoactive mushroom.

Key Takeaways

  • Reishi is not psychedelic. No source we read lists hallucinations as a reishi effect.
  • Reishi's main compounds are beta-glucans and triterpenes. Psilocybin mushrooms contain psilocybin, and Amanita muscaria contains ibotenic acid and muscimol.
  • Psychedelics act on serotonin 5-HT2A receptors. No source we read describes a reishi compound that does this.
  • Psilocybin is a Schedule I drug at the federal level. Amanita muscaria is not a controlled substance, but the FDA does not allow it in conventional food.
  • Human evidence for reishi is limited, and the FDA has not approved it to treat any condition.
  • Reishi can cause nausea and insomnia. Rare liver injury has been reported, and blood thinners are the main interaction concern.
  • A product that causes hallucinations may not be what its label says. Call Poison Help at 1-800-222-1222.

Reishi vs Psilocybin Mushrooms vs Amanita muscaria

Reishi differs from both psychoactive mushrooms in its compounds, its effects, its legal status and its main risks. This table compares all three.

Side-by-side chart comparing reishi, psilocybin mushrooms and Amanita muscaria by compounds, effect, legal status and risks
FeatureReishiPsilocybin mushroomsAmanita muscaria
Main compoundsBeta-glucans and triterpenesPsilocybin, which the body converts to psilocinIbotenic acid and muscimol
How they actStudied for immune activity. No hallucinogenic action reported in the sources we readAct on serotonin 5-HT2A receptorsIbotenic acid resembles glutamate. Muscimol resembles GABA
Main effectNo high or hallucinations expectedAltered perception, strong emotions, hallucinationsStomach upset with agitation, hallucinations or sedation
US federal statusLegal. Sold as a dietary supplementSchedule I. Possession is illegalNot a controlled substance. Not authorized in conventional food
SafetyNausea, insomnia, rare liver injury, bleeding riskPanic, raised heart rate and blood pressure, lasting psychosis, fatal mix-ups with poisonous mushroomsPoisoning, seizures and, in one CDC case, respiratory failure

Reishi details come from Memorial Sloan Kettering's About Herbs page (MSK) and the National Cancer Institute. Psilocybin details come from the National Center for Complementary and Integrative Health (NCCIH). Amanita muscaria details come from a CDC report and an FDA notice dated December 18, 2024. An NPR report confirms that Amanita muscaria is not a controlled substance. The FDA is still evaluating these ingredients in dietary supplements. State laws vary, and this table covers federal status only.

Why Is Reishi Not Psychedelic?

Reishi is not psychedelic because its known active compounds are not psychedelic drugs. A review in Pharmacological Reviews explains that psychedelics act on serotonin 5-HT2A receptors in the brain. The body converts psilocybin to psilocin, which has effects similar to LSD.

Reishi has a different chemical profile. MSK names beta-glucan polysaccharides and triterpenes as its active constituents. The National Cancer Institute also lists lipids and proteins. Beta-glucans are long chains of sugar molecules, and MSK describes them as immune-stimulating in research. We found no study reporting psilocybin or psilocin in reishi. No source we read describes a reishi compound that activates 5-HT2A receptors.

Biology points the same way. A 2018 paper in Evolution Letters places psilocybin-producing mushrooms in scattered families of the order Agaricales. Reishi belongs to the family Ganodermataceae, in the order Polyporales. Our guide to the Ganoderma lucidum group covers the fungi behind the reishi name.

Can Reishi Make You Feel High?

No, reishi is not expected to make you feel high. MSK lists nausea, insomnia, dry mouth, constipation, itching and vertigo among reported reactions. None of those is a psychedelic effect, although vertigo can feel strange.

Some people take reishi hoping for calm or better sleep. Human evidence on that is limited, and insomnia is one of the reported side effects. Calm or drowsiness would not make a substance psychedelic anyway.

MSK also mentions acute neurotoxicity in a child who was taking several medicinal fungi supplements. That report involved multiple products, so it does not show that reishi alone caused the problem.

Why Do People Confuse Reishi With Magic Mushrooms?

People confuse them because the word mushroom covers very different organisms and products. These are the main mix-ups.

Reishi Ganoderma tsugae, a glossy red-brown shelf on a dead hemlock log, AI illustration

Different Kinds of Mushroom

Reishi is a hard, shiny shelf fungus with pores on its underside, according to the Missouri Department of Conservation. Psilocybin mushrooms belong to Agaricales, the main group of gilled mushrooms. Our article on what mushroom gills do explains that structure.

Medicinal Does Not Mean Psychoactive

Reishi is often sold beside lion's mane, turkey tail and chaga. None of these belongs to the psilocybin-producing families named in the Evolution Letters paper. Our medicinal mushroom identification guide explains how these species differ.

Psychoactive Does Not Mean Psychedelic

Amanita muscaria is psychoactive, but its chemistry differs from psilocybin. The CDC report says ibotenic acid can cause hallucinations, agitation or seizures. It says muscimol depresses the central nervous system. No source we read lists either compound in reishi.

Psilocybin Research Is Not Reishi Research

News about psilocybin trials can color how people see all mushroom supplements. NCCIH reports that the FDA gave psilocybin-assisted psychotherapy breakthrough therapy designation in 2018 and 2019. That designation speeds development, and it is not an approval. It does not apply to reishi.

What Reishi Supplements Can and Cannot Do

Human evidence for reishi is limited, and the FDA has not approved it to treat any disease. The National Cancer Institute says the FDA has not approved medicinal mushrooms as a treatment for cancer or any other condition.

ClaimWhat the evidence showsVerdict
Causes a high or hallucinationsNo source we read lists this effectNo
Treats cancerEvidence is insufficient for first-line use, and the effect on survival is unknownNot shown
Supports the immune systemA Cochrane review found small rises in some immune cell measures. A 36-person lung cancer trial found measures largely unchangedUncertain
Improves blood sugar, blood pressure or cholesterol in type 2 diabetesFive trials with 398 people did not support this useNot supported
Eases urinary symptoms in menMSK reports that clinical trials support a benefitSome support
Helps fibromyalgia or Alzheimer's diseaseTrials found no change in blood or body measures in fibromyalgia. A pilot study found no help in Alzheimer's diseaseNot supported

The cancer row comes from a 2016 Cochrane review of five randomized trials. Its authors judged trial quality as generally poor. They said reishi might be considered alongside conventional treatment, but they urged caution and better trials. The diabetes row comes from a 2015 Cochrane review.

What Are the Side Effects of Reishi?

Reishi side effects are usually minor, although serious reactions have been reported. The National Cancer Institute describes reishi products as generally well tolerated in cancer trials. The 2015 Cochrane review found more adverse events with reishi than with placebo. That difference was not statistically significant, and the events were not serious.

MSK also describes rarer problems:

  • A reported case involved high eosinophil counts and liver nodules that resolved after stopping reishi.
  • Reishi's immune effects may trigger or worsen autoimmune skin disease, although the cause is undetermined.
  • Spore powder may raise CA72-4, a tumor marker, which could affect cancer test results.

Can Reishi Damage the Liver?

Reishi has been linked to rare cases of liver injury, including one death, but case reports do not prove cause. The LiverTox record from the National Institutes of Health says reishi is well tolerated and has not been linked to raised liver enzymes during therapy. It also says reishi has been implicated in rare single cases of acute liver injury. In most of those reports, other causes were not adequately ruled out.

Two published cases involved powder:

  • A 78-year-old woman took Lingzhi for a year and then switched to a powdered product. About a month later, she had fatigue and dark urine. Her liver tests were near normal five months later.
  • A 2007 report in the Journal of the Medical Association of Thailand described fatal fulminant hepatitis associated with Lingzhi powder. The injury appeared 1 to 2 months after a switch from boiled Lingzhi to powder.

Two cases cannot show that powder is riskier than other forms. Stop the product and call a clinician if you notice yellow skin or eyes, dark urine or unexplained fatigue.

What Does Reishi Interact With, and Who Should Avoid It?

Blood thinners are the main interaction concern, followed by drugs that suppress the immune system. These points come from MSK.

  • Blood thinners and antiplatelet drugs: Reishi can increase bleeding risk. Extracts may also prolong clotting tests such as INR, PT and aPTT.
  • Immunosuppressants: Reishi may enhance the immune response. MSK advises asking your provider first.
  • Chemotherapy: Reishi may increase antioxidant capacity. In theory, this could interfere with drugs that rely on free radicals.
  • Drugs cleared by liver enzymes: Reishi polysaccharides inhibited CYP2E1, CYP1A2 and CYP3A in lab tests. The clinical relevance is unknown.

Talk to a doctor or pharmacist first if you take any of these drugs. Do the same if you have liver disease or an autoimmune condition. Tell your surgeon about reishi before any procedure, because of the bleeding concern. MSK does not address pregnancy or breastfeeding, so ask a clinician first in those situations too.

What If a Reishi Product Makes You Feel Altered?

Hallucinations or severe confusion after a reishi product are a warning sign, not a normal reishi effect. The product may contain something else, or another substance may be involved. We found no report of a reishi supplement containing psilocybin. Other mushroom-branded products have contained undeclared drugs, however:

  • A 2025 JAMA Network Open study, described by Oregon State University, tested 12 gummies and chocolates labeled as magic mushroom products. None contained psilocybin. Testing found undisclosed caffeine, hemp and kava extracts, and synthetic psychedelics.
  • A 2026 CDC report described 180 illness cases in 34 states tied to mushroom-containing chocolate products in 2024. Testing found muscimol, psilocin, kavalactones, acetylpsilocin and pregabalin. In all, 73 people were hospitalized and 2 died.
  • NCCIH warns that psilocybin products may be adulterated with dangerous substances such as fentanyl.

Those products were not reishi supplements. They show only that a mushroom label does not guarantee the contents. The National Cancer Institute also warns that ingredient amounts in supplements can vary between lots.

Call Poison Help at 1-800-222-1222 for advice. Call 911 for seizures, trouble breathing, collapse or severe confusion. Keep the package so clinicians can see what was taken.

Common Identification Mistakes

Calling Any Red Mushroom Reishi

Reishi and Amanita muscaria can both be red. Reishi is a hard shelf with pores. Amanita muscaria has a capped shape with white gills, a ring and a stalk. A mushroom with gills is not reishi.

Calling Every Shiny Shelf Fungus Reishi

Many shelf fungi grow on trees, and names change too. Missouri now lists its reishi as Ganoderma sessile, formerly G. lucidum. Our tree mushroom identification guide covers the wider group.

Assuming Medicinal Means Safe to Eat

A wild shelf fungus still needs expert confirmation. Missouri's field guide calls reishi too tough to be a good edible. Read poisonous vs edible mushrooms before you trust any wild find.

Frequently Asked Questions

Are reishi mushrooms psychedelic?

No. Reishi's main active compounds are beta-glucans and triterpenes, and reishi is not known to cause hallucinations. We found no study reporting psilocybin in it.

Will reishi make me hallucinate?

Reishi is not expected to cause hallucinations. Reported side effects include nausea, insomnia, dry mouth, itching and vertigo. If a product labeled reishi causes hallucinations, stop taking it and call Poison Help at 1-800-222-1222.

Is reishi related to magic mushrooms?

Only distantly. Both are fungi, but reishi belongs to the family Ganodermataceae in the order Polyporales. Psilocybin-producing mushrooms belong to families in the order Agaricales.

Is Amanita muscaria psychedelic?

Amanita muscaria is psychoactive, but it does not work the way psilocybin does. Its main compounds are ibotenic acid and muscimol, which resemble glutamate and GABA. It can cause serious poisoning.

Are lion's mane, turkey tail and chaga psychedelic?

These mushrooms are not in the psilocybin-producing families described in the research we read. They are sold as supplements, not as psychedelics. Mushroom-branded edibles are a separate product type, and their labels cannot always be trusted.

Is reishi legal in the US?

Yes. Reishi is sold as a dietary supplement and is not a federally controlled substance. The FDA has not approved it as a treatment for cancer or any other condition.

Can reishi show up on a drug test?

We found no published case of reishi causing a positive drug test. That is not proof that it cannot happen. A mislabeled product could contain another substance, so tell the testing lab what you took.

Is reishi bad for your liver?

Liver injury from reishi appears to be rare. LiverTox says reishi is well tolerated, although rare single cases of acute liver injury have been reported. One report involving reishi powder was fatal, so see a clinician for yellow skin or dark urine.

Can you take reishi with blood thinners?

Ask your doctor or pharmacist first. MSK warns that reishi can increase bleeding risk. Extracts may also affect clotting test results.

Final Safety Reminder

Reishi is not psychedelic, but it is an active supplement. Tell your doctor or pharmacist before you start it, especially if you take blood thinners or immune-suppressing drugs. Call Poison Help at 1-800-222-1222 if a mushroom or mushroom product causes symptoms, and call 911 in an emergency. Never eat a wild mushroom based on a chart, a photo or an app. If you found a shelf fungus and want a second opinion, check clear photos with our free mushroom identifier and a local expert.


Comments

Sign in to leave a comment and join the discussion.

30 Free Credits · No Credit Card Required

Start Identifying Safely Today

Join thousands of foragers using AI-powered identification

30 free creditsNo credit card requiredCancel anytimePremium plans: 7-day free trial